Hikma Pharmaceutical reported 4M in Interest Income for its fiscal semester ending in December of 2024.


Interest Income Change Date
Almirall 2M 1.44M Mar/2025
argenx SE 38.4M 1.28M Jun/2025
AstraZeneca 68M 16M Jun/2025
Autolus Therapeutics Ltd 6.14M 1.31M Mar/2025
Bayer 92M 22M Mar/2025
Galapagos EUR 12.56M 4.66M Mar/2025
Genmab DKK 25M 8M Jun/2025
GlaxoSmithKline 50M 4M Jun/2025
GRIFOLS 9.56M 4.5M Jun/2025
Hikma Pharmaceutical 4M 0 Dec/2024
Merck 17M 11M Jun/2025
Roche Holding 2M 12M Dec/2020
Sanofi 76M 10M Jun/2025